Key opinion leaders, Professor Martin Dreyling and Professor Tarec El-Galaly analyse efficacy and tolerability data for new treatment regimens for Mantle Cell Lymphoma from key trials presented at ASH 2023.

Key opinion leaders,  Professor Tarec El-Galaly and Professor Martin Dreyling analyse efficacy and tolerability data for new treatment regimens for Mantle Cell Lymphoma from key trials presented at ASH 2023.

Mantle Cell Lymphoma – Clinical Evaluation, Diagnosis, and Novel Treatments Highlights from the 65th 2023 American Society of Hematology (ASH) Annual Meeting & Exposition on Blood and Bone Marrow Disorders and some sessions dedicated to ‘Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas’ DOWNLOAD PDF VERSION Abstract A conference on malignant and non-malignant hematology